Australian Clinical Labs Ltd (AU:ACL) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Australian Clinical Labs Ltd has experienced a shift in its substantial holdings as KKR Entities, including Comet Asia Holdings and KKR Asia III Fund, have ceased to be major shareholders as of October 24, 2024. This change in shareholding dynamics may stir interest among investors monitoring the company’s market position and stock performance.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.